InvestorsHub Logo
Followers 6
Posts 685
Boards Moderated 0
Alias Born 11/21/2013

Re: Myth post# 65231

Wednesday, 02/14/2024 5:16:52 PM

Wednesday, February 14, 2024 5:16:52 PM

Post# of 65575
Myth, I don't disagree that this makes SHMN like the rest of the pinks...that was part of my point.

It was noted that following this stock is like groundhog's day. I agreed insomuch as the "day" that we are repeating is in the form of a dribble of news that incrementally boosts PPS, only to see it fall again in the absence of further clarity, tangible results in OTC filings, and a failure to sustain whatever effort started the cycle in the first place. I fully agree this is par for the course in OTC land. It's why we see so many short lived pumps/runs, and so many companies whose PPS goes in the tank after days of zero volume because someone gets bored and decides to dump off $1.50 worth of shares.

I agree that the ABBIE announcement is absolutely substantive. But if it is going to drive a persistent and sustained increase in PPS, there needs to be a tangible benefit associated with it (in Q1 we are licensing ABBIE to Geneco for $XXXX), public disclosure verifying the benefit (Revenues have increased by $XXXX this quarter), and be repeatable (In addition to Geneco, in Q2 we are licensing ABBIE to DNACo for $YYYY, etc.). I'm not saying that these things won't happen; indeed I remain extremely hopeful that they will. Instead, I point out that until they do, the announcements around ABBIE can't be expected to have a lasting impact.